- Home
- GAU vs TKNO Comparison
GAU vs TKNO Comparison
Compare GAU & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAU
- TKNO
- Stock Information
- Founded
- GAU 1999
- TKNO 1996
- Country
- GAU Canada
- TKNO United States
- Employees
- GAU N/A
- TKNO N/A
- Industry
- GAU
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- GAU
- TKNO Health Care
- Exchange
- GAU Nasdaq
- TKNO Nasdaq
- Market Cap
- GAU 408.3M
- TKNO 256.9M
- IPO Year
- GAU N/A
- TKNO 2021
- Fundamental
- Price
- GAU $2.16
- TKNO $4.35
- Analyst Decision
- GAU Strong Buy
- TKNO
- Analyst Count
- GAU 2
- TKNO 0
- Target Price
- GAU $3.00
- TKNO N/A
- AVG Volume (30 Days)
- GAU 2.7M
- TKNO 224.0K
- Earning Date
- GAU 08-13-2025
- TKNO 08-07-2025
- Dividend Yield
- GAU N/A
- TKNO N/A
- EPS Growth
- GAU N/A
- TKNO N/A
- EPS
- GAU N/A
- TKNO N/A
- Revenue
- GAU $309,575,000.00
- TKNO $38,923,000.00
- Revenue This Year
- GAU $80.61
- TKNO $9.52
- Revenue Next Year
- GAU $43.30
- TKNO $15.20
- P/E Ratio
- GAU N/A
- TKNO N/A
- Revenue Growth
- GAU 223.63
- TKNO 11.40
- 52 Week Low
- GAU $1.00
- TKNO $4.00
- 52 Week High
- GAU $2.19
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- GAU 77.92
- TKNO 43.35
- Support Level
- GAU $2.09
- TKNO $4.22
- Resistance Level
- GAU $2.16
- TKNO $4.94
- Average True Range (ATR)
- GAU 0.10
- TKNO 0.29
- MACD
- GAU 0.02
- TKNO -0.00
- Stochastic Oscillator
- GAU 97.64
- TKNO 16.75
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.